New York, USA, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Chronic Pain Clinical Trial Pipeline Experiences Momentum ... Centrexion Therapeutics, Neumentum Inc., Grünenthal, Synerkine Pharma, Intra ...

(MENAFN- GlobeNewsWire - Nasdaq) Chronic Pain, that persists beyond the usual recovery period or occurs along with a chronic health condition, such as arthritis. The rising prevalence of chronic ...

Analyst Sam Slutsky of LifeSci Capital maintained a Buy rating on Immunovant (IMVT – Research Report), retaining the price target of ...

TOKYO, Jan 31 (Reuters) - Japan is considering offering support for a $44 billion gas pipeline in Alaska as it seeks to court U.S. President Donald Trump and forestall potential trade friction ...

Former Lioness Jill Scott said she does not think she would be able to "survive nowadays" due to the technical level of girls' football. She returned to Sunderland alongside former referee Rebecca ...

$500 million upfront and a total deal value of up to $5 billion sounds like a deal made by a top-tier pharma company – but, in fact, it comes from diminutive biotech Summit Therapeutics.

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...

Eaton Vance Short Duration High IncomeFd earns a High Process Pillar rating. The primary contributor to the rating is its parent firm's excellent long-term risk-adjusted performance, as shown by ...

After hours: February 4 at 4:03:53 PM EST Loading Chart for TCRX ...

After hours: February 4 at 4:20:00 PM EST Loading Chart for CLDX ...

Sanofi S.A. Part Cert 0.02% €8.03M ...